AI-generated summary
The authors report a randomized, double-blind trial of 40 patients with recurrent herpes labialis comparing photobiomodulation therapy at 650 nm with acyclovir cream plus passive laser. Pain was reduced significantly faster with photobiomodulation, but healing time did not differ between groups. The authors describe photobiomodulation as a promising possible alternative, though the abstract does not establish its effectiveness.
- Participants
- 40
- Who or what was studied
- Patients with recurrent herpes labialis
- Wavelengths
- 650 nm
- Limits stated in the abstract
- The abstract reports no difference in clinical healing time between groups and describes the treatment as only possibly an alternative, so evidence for effectiveness is limited.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 650 nm
- Energy density (fluence)
- 4.7 J/cm2
- Power
- 100 mW
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Randomized controlled trial, Control group, Laser, Trial registration. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.